Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma

Granata, Vincenza; Fusco, Roberta; Belli, Andrea; Borzillo, Valentina; Palumbo, Pierpaolo; Bruno, Federico; Grassi, Roberta; Ottaiano, Alessandro; Nasti, Guglielmo; Pilone, Vincenzo; Petrillo, Antonella; Izzo, Francesco

doi:10.1186/s13027-022-00438-y

Cited by 2 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the increasing incidence of CCA, several studies have focused on improving the diagnosis, prognosis, and treatment of patients [ 3 ]. CCA diagnosis is routinely achieved through serum markers (CA 19-9, CEA) and radiologic imaging, but in atypical cases, differential diagnosis can be still challenging, so biopsy remains the only tool for definitive diagnosis [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

“…As depicted above, ICC represents a natural field of interest of radiomics tools due to its ability to exhibit atypical behavior that makes, in some cases, the diagnosis and the subsequent treatment strategy very challenging [ 4 , 5 , 6 ]. The aim of this review is to report the results of several studies and the real application of radiomics in clinical practice in the large field of diagnosis.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background: This paper offers an assessment of radiomics tools in the evaluation of intrahepatic cholangiocarcinoma. Methods: The PubMed database was searched for papers published in the English language no earlier than October 2022. Results: We found 236 studies, and 37 satisfied our research criteria. Several studies addressed multidisciplinary topics, especially diagnosis, prognosis, response to therapy, and prediction of staging (TNM) or pathomorphological patterns. In this review, we have covered diagnostic tools developed through machine learning, deep learning, and neural network for the recurrence and prediction of biological characteristics. The majority of the studies were retrospective. Conclusions: It is possible to conclude that many performing models have been developed to make differential diagnosis easier for radiologists to predict recurrence and genomic patterns. However, all the studies were retrospective, lacking further external validation in prospective and multicentric cohorts. Furthermore, the radiomics models and the expression of results should be standardized and automatized to be applicable in clinical practice.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…Radiomic features about tissue and lesion characteristics (such as shape, grayscale, and texture) can be used alone or in combination with demographic, histologic, and genomic data in order to develop predictive or prognostic models. Radiomics is a tool that is planned to be used by clinicians as a guide in precise medical decisions [ 102 , 103 ].…”

Section: Introductionmentioning

confidence: 99%

Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives

Cerrito

Ainora

Borriello

et al. 2023

Cancers

View full text Add to dashboard Cite

Intrahepatic cholangiocarcinoma (iCCA) represents the second most common liver cancer after hepatocellular carcinoma, accounting for 15% of primary liver neoplasms. Its incidence and mortality rate have been rising during the last years, and total new cases are expected to increase up to 10-fold during the next two or three decades. Considering iCCA’s poor prognosis and rapid spread, early diagnosis is still a crucial issue and can be very challenging due to the heterogeneity of tumor presentation at imaging exams and the need to assess a correct differential diagnosis with other liver lesions. Abdominal contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) plays an irreplaceable role in the evaluation of liver masses. iCCA’s most typical imaging patterns are well-described, but atypical features are not uncommon at both CT and MRI; on the other hand, contrast-enhanced ultrasound (CEUS) has shown a great diagnostic value, with the interesting advantage of lower costs and no renal toxicity, but there is still no agreement regarding the most accurate contrastographic patterns for iCCA detection. Besides diagnostic accuracy, all these imaging techniques play a pivotal role in the choice of the therapeutic approach and eligibility for surgery, and there is an increasing interest in the specific imaging features which can predict tumor behavior or histologic subtypes. Further prognostic information may also be provided by the extraction of quantitative data through radiomic analysis, creating prognostic multi-parametric models, including clinical and serological parameters. In this review, we aim to summarize the role of contrast-enhanced imaging in the diagnosis and management of iCCA, from the actual issues in the differential diagnosis of liver masses to the newest prognostic implications.

show abstract

Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma

Cited by 2 publications

References 1 publication

Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma

Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma

Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives

Contact Info

Product

Resources

About